+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ezetimibe"

Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Lipid Regulators Market Report 2025 - Product Thumbnail Image

Lipid Regulators Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Hyperlipidemia Market Report 2025 - Product Thumbnail Image

Hyperlipidemia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
ACE/ARB Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

ACE/ARB Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
Inclisiran - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Inclisiran - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Dyslipidemia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Dyslipidemia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
From
From
Loading Indicator

Ezetimibe is a cholesterol-lowering drug used to treat high cholesterol and other lipid disorders. It works by reducing the absorption of cholesterol from the intestine, thereby reducing the amount of cholesterol in the blood. Ezetimibe is often used in combination with statins, another type of cholesterol-lowering drug, to further reduce cholesterol levels. It is also used to reduce the risk of cardiovascular events, such as heart attack and stroke, in people with existing cardiovascular disease. Ezetimibe is a relatively new drug, having been approved by the US Food and Drug Administration in 2002. It is now widely used in the treatment of high cholesterol and other lipid disorders, and is increasingly being used in combination with statins to further reduce cholesterol levels. Ezetimibe is marketed by several pharmaceutical companies, including Merck, Pfizer, Sanofi, and Daiichi Sankyo. It is also available in generic form from several generic drug manufacturers. Show Less Read more